Literature DB >> 3672053

Infective aortitis due to Brucella melitensis.

J M Aguado1, C Barros, J L Gomez Garces, M L Fernández-Guerrero.   

Abstract

Infective aneurysms caused by Brucella sp. are extremely rare. B. suis and B. abortus have been implicated in a few cases but to our knowledge, B. melitensis has not been reported as a cause of mycotic aneurysm of the abdominal aorta. We here report the first case of this described in the English literature. The patient was successfully treated with resection of the infected aneurysm, placement of an axillo-bifemoral graft, and prolonged antibiotic treatment (doxycycline and streptomycin). Extended antimicrobial therapy and extra-anatomical bypass grafting procedures are advisable in the management of brucella infections of the abdominal aorta.

Entities:  

Mesh:

Year:  1987        PMID: 3672053     DOI: 10.3109/00365548709021683

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  Brucella arteritis: clinical manifestations, treatment, and prognosis.

Authors:  Jesica A Herrick; Robert J Lederman; Brigit Sullivan; John H Powers; Tara N Palmore
Journal:  Lancet Infect Dis       Date:  2014-01-28       Impact factor: 25.071

2.  Thrombosis of the abdominal aorta secondary to Brucella spondylitis.

Authors:  J Sanchez-Gonzalez; T Garcia-Delange; F Martos; J D Colmenero
Journal:  Infection       Date:  1996 May-Jun       Impact factor: 3.553

3.  Vasculopathic changes in the cerebral arterial system with neurobrucellosis.

Authors:  I Adaletli; S Albayram; B Gurses; H Ozer; M H Yilmaz; F Gulsen; A Sirikci
Journal:  AJNR Am J Neuroradiol       Date:  2006-02       Impact factor: 3.825

4.  ACCF/AHA/CDC Conference report on emerging infectious diseases and biological terrorism threats. Task force I: direct cardiovascular implications of emerging infectious diseases and biological terrorism threats.

Authors:  Larry M Baddour; Zhi-Jie Zheng; Darwin R Labarthe; Siobhán O'Connor
Journal:  J Am Coll Cardiol       Date:  2007-03-27       Impact factor: 24.094

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.